FLU-ID regimen

chemotherapy protocol consisting of fludarabine and idarubicin; used in treatment of mantle cell lymphomas

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FLU-ID regimen: 1
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FLU-ID regimen: 1
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - FLU-ID regimen: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        Vidarabine: 560
        FLU-ID regimen: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - Vidarabine: 560
        FLU-ID regimen: 1
  - Arabinonucleosides: 1
    - Vidarabine: 560
      - FLU-ID regimen: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Idarubicin: 927
        FLU-ID regimen: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927
        FLU-ID regimen: 1
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927
        FLU-ID regimen: 1

Experts

1.	Battista, R: 1 article (02/2000)
2.	Bendandi, M: 1 article (02/2000)
3.	Cellini, C: 1 article (02/2000)
4.	Ciccone, F: 1 article (02/2000)
5.	De Renzo, A: 1 article (02/2000)
6.	Gentilini, P: 1 article (02/2000)
7.	Gherlinzoni, F: 1 article (02/2000)
8.	Gobbi, M: 1 article (02/2000)
9.	Guardigni, L: 1 article (02/2000)
10.	Lauta, V M: 1 article (02/2000)

Related Diseases

1.	Lymphoma (Lymphomas) 02/01/2000 - "Although the FLU-ID regimen may not significantly improve the induction of CR in most indolent-lymphoma patients, our preliminary data do suggest that, with respect to FLU alone, it may be capable of conferring a longer-lasting CR and that it might be superior in terms of CR rate in small lymphocytic and immunocytoma subtypes."